Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Liu

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Annals of Surgery|November 2, 2023
Transforming the Future of Surgeon-ScientistsDaniela P Ladner, Allan M Goldstein, Timothy R Billiar, et al.
Annals of Surgical Oncology|January 28, 2025
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Cell|January 17, 2026
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activityJason S Rush, Joshua D Wertheimer, Steven D Goldberg, et al.
Annals of Surgery|November 2, 2023
Transforming the Future of Surgeon-ScientistsDaniela P Ladner, Allan M Goldstein, Timothy R Billiar, et al.
Annals of Surgical Oncology|January 28, 2025
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Pageof 8